6618 — JD Health International Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeLarge CapHigh Flyer

Annual income statement for JD Health International, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	30,682	46,736	53,530	58,160	73,441
Cost of Revenue
Gross Profit	7,197	9,892	11,865	13,309	18,199
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	31,903	46,701	52,636	54,914	68,874
Operating Profit	-1,221	35.6	894	3,246	4,568
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-901	696	2,693	4,797	6,030
Provision for Income Taxes
Net Income After Taxes	-1,073	383	2,143	4,157	5,367
Minority Interest
Net Income Before Extraordinary Items
Net Income	-1,074	380	2,142	4,162	5,375
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-1,074	380	2,142	4,162	5,375
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.347	0.121	0.677	1.32	1.72